Literature DB >> 18231963

Colonoscopy results of a French regional FOBT-based colorectal cancer screening program with high compliance.

S Manfredi1, C Piette, G Durand, G Plihon, G Mallard, J-F Bretagne.   

Abstract

BACKGROUND AND STUDY AIMS: Mass screening for colorectal cancer in France was initiated in pilot regions on the basis of the fecal occult blood test (FOBT) followed by colonoscopy in positive cases. We report the colonoscopy results in one of the first areas to be screened (Ille et Vilaine). PATIENTS AND METHODS: Of the total regional population of 908,449, 187,342 of the 213,635 potential screening candidates who were aged 50 - 74 years were invited for FOBT. Of the 51.3% compliant individuals, 2.6% were positive, and of these 90.7% agreed to undergo colonoscopy (n = 2246). The colonoscopy procedure details, findings, and complications were recorded. Subjects were classified according to the most advanced lesion. Positive predictive values of FOBT were calculated according to sex and age.
RESULTS: Colonoscopy was complete in 96.3% of cases. Only 23 adverse events were encountered (1.02%). Colorectal cancer was diagnosed in 237 cases (10.6%, 78.4% of which were clinical stages I - II). The rates of overall adenomas and advanced adenomas were 33.1 % and 21.6 %, respectively. The risk of cancer and advanced adenoma increased significantly in men and in older people.
CONCLUSION: The results of mass screening with FOBT followed by colonoscopy in this population-based study are very encouraging in terms of compliance, early findings, and complications. Extension of this program to the whole of France is justified.

Entities:  

Mesh:

Year:  2008        PMID: 18231963     DOI: 10.1055/s-2007-995430

Source DB:  PubMed          Journal:  Endoscopy        ISSN: 0013-726X            Impact factor:   10.093


  12 in total

1.  The influence of waiting times on cost-effectiveness: a case study of colorectal cancer mass screening.

Authors:  Pauline Chauvin; Jean-Michel Josselin; Denis Heresbach
Journal:  Eur J Health Econ       Date:  2013-08-22

2.  Incremental net benefit and acceptability of alternative health policies: a case study of mass screening for colorectal cancer.

Authors:  Pauline Chauvin; Jean-Michel Josselin; Denis Heresbach
Journal:  Eur J Health Econ       Date:  2011-02-09

3.  Colorectal cancer screening in Canada: results from the first round of screening for five provincial programs.

Authors:  D Major; H Bryant; M Delaney; S Fekete; L Gentile; M Harrison; V Mai; E Nicholson; Y Taylor
Journal:  Curr Oncol       Date:  2013-10       Impact factor: 3.677

Review 4.  Gastroscopy following a positive fecal occult blood test and negative colonoscopy: systematic review and guideline.

Authors:  Johane Allard; Roxanne Cosby; M Elisabeth Del Giudice; E Jan Irvine; David Morgan; Jill Tinmouth
Journal:  Can J Gastroenterol       Date:  2010-02       Impact factor: 3.522

5.  The compliance rate for the second diagnostic evaluation after a positive fecal occult blood test: A systematic review and meta-analysis.

Authors:  Rachel Gingold-Belfer; Haim Leibovitzh; Doron Boltin; Nidal Issa; Tsachi Tsadok Perets; Ram Dickman; Yaron Niv
Journal:  United European Gastroenterol J       Date:  2019-02-06       Impact factor: 4.623

6.  For "difficult" benign colorectal lesions referred to surgical resection a second opinion by an experienced endoscopist is mandatory: A single centre experience.

Authors:  Carmelo Luigiano; Giuseppe Iabichino; Nico Pagano; Leonardo Henry Eusebi; Stefania Miraglia; Antonino Judica; Angela Alibrandi; Clara Virgilio
Journal:  World J Gastrointest Endosc       Date:  2015-07-25

7.  Colorectal cancer screening with odour material by canine scent detection.

Authors:  Hideto Sonoda; Shunji Kohnoe; Tetsuro Yamazato; Yuji Satoh; Gouki Morizono; Kentaro Shikata; Makoto Morita; Akihiro Watanabe; Masaru Morita; Yoshihiro Kakeji; Fumio Inoue; Yoshihiko Maehara
Journal:  Gut       Date:  2011-01-31       Impact factor: 23.059

8.  Social inequalities in a population based colorectal cancer screening programme in the Basque Country.

Authors:  Jose Luis Hurtado; Amaia Bacigalupe; Montse Calvo; Santi Esnaola; Nere Mendizabal; Isabel Portillo; Isabel Idigoras; Eduardo Millán; Eunate Arana-Arri
Journal:  BMC Public Health       Date:  2015-10-05       Impact factor: 3.295

9.  Detection of gas components as a novel diagnostic method for colorectal cancer.

Authors:  Atsushi Ishibe; Mitsuyoshi Ota; Akemi Takeshita; Hiroshi Tsuboi; Satoko Kizuka; Hidenori Oka; Yusuke Suwa; Shinsuke Suzuki; Kazuya Nakagawa; Hirokazu Suwa; Masashi Momiyama; Jun Watanabe; Masataka Taguri; Chikara Kunisaki; Itaru Endo
Journal:  Ann Gastroenterol Surg       Date:  2018-01-11

10.  Colon mucosal neoplasia referred for endoscopic mucosal resection: Recurrence of adenomas and prediction of submucosal invasion.

Authors:  Mamoon Ur Rashid; Neelam Khetpal; Hammad Zafar; Saeed Ali; Evgeny Idrisov; Yuan Du; Assaf Stein; Deepanshu Jain; Muhammad Khalid Hasan
Journal:  World J Gastrointest Endosc       Date:  2020-07-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.